The Role of Functional MR Imaging in the Assessment of Tumor Response after Chemoembolization in Patients with Hepatocellular Carcinoma

This publication has 29 references indexed in Scilit:

• Therapeutic Efficacy of DTI-015 using Diffusion Magnetic Resonance Imaging as an Early Surrogate Marker
  Clinical Cancer Research, 2004
• Early Detection of Response to Radiation Therapy in Patients With Brain Malignancies Using Conventional and High b-Value Diffusion-Weighted Magnetic Resonance Imaging
  Journal of Clinical Oncology, 2003
• Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
  Hepatology, 2002
• Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
  The Lancet, 2002
• Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
  Journal of Hepatology, 2001
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI: Journal of the National Cancer Institute, 2000
• Hepatitis C and hepatocellular carcinoma
  Hepatology, 1997
• Transcatheter Arterial Chemoembolization in Inoperable Hepatocellular Carcinoma: Four-year Follow-up
  Journal of Vascular and Interventional Radiology, 1996
• Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
  American Journal of Roentgenology, 1994
• Detection of Viable Tumor Cells in Hepatocellular Carcinoma Following Transcatheter Arterial Chemoembolization with Iodized Oil
  Acta Radiologica, 1993